A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/30 (2006.01) A61K 9/00 (2006.01) A61K 9/16 (2006.01) A61K 9/20 (2006.01)
Patent
CA 2477593
The invention relates to novel, sustained-release IGF-I therapeutic compositions, a preparation and production method thereof and the use of same in the production of medicaments for the treatment and prevention of neurodegenerative diseases such as, among others, Alzheimer's disease or cerebellar ataxia. The inventive compositions take the form of microspheres having a size of less than 5 micrometres, among other characteristics, and subcutaneous implantation capsules.
L'invention concerne de nouvelles compositions thérapeutiques d'administration lente de IGF-I, un procédé de préparation et d'obtention de celles-ci, et leur utilisation dans l'élaboration de médicaments utilisés dans le traitement et la prévention de maladies neurodégénératives telles que, entre autres, la maladie d'Alzheimer ou l'ataxie cérébelleuse. Ces compositions s'adaptent à des microsphères de dimension inférieure à 5 micromètres, entre autres caractéristiques, et à des capsules d'implantation sous-cutanée.
Carrascosa Martinez Celia
Carro Diaz Eva Maria
Lopez Lopez Cristina
Torrado Duran Juan Jose
Torrado Duran Santiago
Carrascosa Celia
Consejo Superior de Investigaciones Cientificas
Fetherstonhaugh & Co.
Universidad Complutense de Madrid
LandOfFree
Chemical igf-i formulation for the treatment and prevention... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chemical igf-i formulation for the treatment and prevention..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chemical igf-i formulation for the treatment and prevention... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1825321